Pancreatic Cell News Volume 12.09 | Mar 9 2021

    0
    59







    2021-03-09 | PACN 12.09


    Pancreatic Cell News by STEMCELL Technologies
    Vol. 12.09 – 9 March, 2021
    TOP STORY

    Type I Collagen Deletion in αSMA+ Myofibroblasts Augments Immune Suppression and Accelerates Progression of Pancreatic Cancer

    Investigators used a dual-recombinase genetic mouse model of spontaneous PDAC to delete type I collagen specifically in myofibroblasts.
    [Cancer Cell]

    AbstractPress ReleaseGraphical Abstract

    Enter a contest to win a personalized lab coat by subscribing to Organoid News!
    PUBLICATIONSRanked by the impact factor of the journal

    Conversion of the Death Inhibitor ARC to a Killer Activates Pancreatic β Cell Death in Diabetes

    Loss of insulin-secreting pancreatic β cells through apoptosis contributes to the progression of type 2 diabetes, but underlying mechanisms remain elusive. The authors identified a pathway in which the cell death inhibitor ARC paradoxically became a killer during diabetes.
    [Developmental Cell]

    AbstractFull ArticleGraphical Abstract

    Premalignant Pancreatic Cells Seed Stealth Metastasis in Distant Organs in Mice

    Investigators showed that premalignant pancreatic cells seed distant stealth metastasis that eventually developed into manifest metastasis.
    [Oncogene]

    Abstract

    Comprehensive Metabolomic Study of the Response of HK-2 Cells to Hyperglycemic Hypoxic Diabetic-Like Milieu

    A comprehensive metabolomic study of the response of HK-2 cells, a human cell line derived from normal proximal tubular epithelial cells, to hyperglycemic, hypoxic diabetic-like milieu has been performed.
    [Scientific Reports]

    Full Article

    Lysosomal Retargeting of Myoferlin Mitigates Membrane Stress to Enable Pancreatic Cancer Growth

    Researchers identified the Ferlin family plasma membrane repair factor Myoferlin as selectively and highly enriched on the membrane of pancreatic cancer lysosomes.
    [Nature Cell Biology]

    Abstract

    ESE3/EHF, a Promising Target of Rosiglitazone, Suppresses Pancreatic Cancer Stemness by Downregulating CXCR4

    The authors identified E26 transformation-specific homologous factor as a key molecule in decreasing the sensitivity of pancreatic cancer cells to cancer stem cells’ niche stimulus.
    [Gut]

    Abstract

    Characterization of Initial Key Steps of IL-17 Receptor B Oncogenic Signaling for Targeted Therapy of Pancreatic Cancer

    Researchers report that interleukin-17 receptor B (IL-17RB) formed a homodimer and recruited mixed-lineage kinase 4, a dual kinase, to phosphorylate it at tyrosine-447 upon treatment with IL-17B in vitro. Higher amounts of phosphorylated IL-17RB in tumor specimens obtained from patients with pancreatic cancer correlated with a worse prognosis.
    [Science Translational Medicine]

    AbstractEditoral

    Tumor-Penetrating Therapy for β5 Integrin-Rich Pancreas Cancer

    Investigators report that carcinoma-associated fibroblasts induced β5 integrin expression in tumor cells in a TGF-β dependent manner, making them an efficient drug delivery target for the tumor-penetrating peptide iRGD.
    [Nature Communications]

    Full ArticlePress Release

    Identification of CD318, TSPAN8 and CD66c as Target Candidates for CAR T Cell Based Immunotherapy of Pancreatic Adenocarcinoma

    Investigators combined an empiric antibody-based flow cytometry screen with a cyclic immunofluorescence imaging platform and a comprehensive bioinformatical and experimental evaluation for off-tumor expression to identify PDAC-specific cell surface markers.
    [Nature Communications]

    Full Article

    Adaptation of Pancreatic Cancer Cells to Nutrient Deprivation Is Reversible and Requires Glutamine Synthetase Stabilization by mTORC1

    Researchers report the selection for clonal human PDAC cells that survived and adapted to limiting levels of both glucose and glutamine. They found that adapted clones exhibit increased growth in vitro.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Abstract

    Mitochondrial Uncoupler MB1-47 Is Efficacious in Treating Hepatic Metastasis of Pancreatic Cancer in Murine Tumor Transplantation Models

    Scientists synthesized a new mitochondrial uncoupler MB1-47 and tested its effect on cancer cell metabolism and the anticancer activity in pancreatic cancer cell models and murine tumor transplantation models.
    [Oncogene]

    Abstract

    SMAD4 Loss Limits the Vulnerability of Pancreatic Cancer Cells to Complex I Inhibition via Promotion of Mitophagy

    Investigators hypothesized that resistance to ETC inhibitors from the biguanide class could be induced by the inactivation of SMAD4, an important tumor suppressor involved in transforming growth factor β signaling and associated with the altered mitochondrial activity.
    [Oncogene]

    Abstract

    Register for a recorded organoid panel discussion moderated by Dr. James Wells
    REVIEWS

    Metabolic Consequences of Obesity and Type 2 Diabetes: Balancing Genes and Environment for Personalized Care

    The authors explore the genetic and metabolic aspects of diabetes and obesity and discuss some of the latest work and emerging ideas related to basic biological mechanisms, translational research, and clinical applications.
    [Cell]

    Full Article

    INDUSTRY AND POLICY NEWS

    Lilly and Biolojic Design Announce Research Collaboration to Discover and Develop Antibody Therapies for Diabetes

    Eli Lilly and Company and Biolojic Design Ltd. announced a research collaboration and license agreement that will leverage Biolojic’s AI-based multibody platform to discover and develop a potential novel antibody-based therapy for the treatment of diabetes.
    [Eli Lilly and Company]

    Press Release

    FEATURED EVENT

    Microbiology Society Annual Conference 2021

    April 26 – 30, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Fellowship – Diabetes Research

    University of Michigan – Ann Arbor, Michigan, United States

    Faculty and Postdoctoral Positions – Stem Cells and Cancer

    Shanghai Jiao Tong University School of Medicine- Shanghai, China

    Postdoctoral Scientist – Senescence and Cancer

    Cancer Research Center of Lyon – Lyon, France

    Senior Scientist – Assay Development

    CyberCoders – San Diego, California, United States

    Tenure Track Scientist Positions – Metabolism

    Rutgers Robert Wood Johnson Medical School – Rutgers, New Jersey, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Pancreatic Cell News Twitter